Serina Therapeutics Inc (SER)
Official siteHEALTHCARE • BIOTECHNOLOGY • AMEX
Market Cap: $36.93M
Last updated: Nov 17, 2026 at 11:04 AM ET
Serina Therapeutics Inc (SER) Competitors
The companies most similar to Serina Therapeutics are OS Therapies (OSTX), ProMIS Neurosciences (PMN) and Rein Therapeutics (RNTX). By market cap, Serina Therapeutics ranks 8th of the 13 companies on this page; Rani Therapeutics Holdings (RANI) is the largest at $60.78M.
Peer Comparison
SER's ROIC of -109.4% is below the peer median of -91.2%, and its revenue growth of 154.9% is above the median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Serina Therapeutics (SER) | $36.93M | N/A | 288.7x | 0.0% | -109.4% | 154.9% | 0.00% |
| OS Therapies Incorporated (OSTX) | $34.87M | N/A | N/A | 0.0% | 218.0% | 0.0% | 0.00% |
| ProMIS Neurosciences Inc. (PMN) | $29.60M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Rein Therapeutics Inc (RNTX) | $47.63M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Plus Therapeutics Inc (PSTV) | $26.64M | N/A | 2.0x | -230.2% | -827.8% | -2.9% | 0.00% |
| Gain Therapeutics Inc (GANX) | $46.31M | N/A | N/A | 0.0% | -170.5% | -100.0% | 0.00% |
| Seres Therapeutics Inc (MCRB) | $14.27M | N/A | 6.6x | 0.0% | N/A | 68.9% | 0.00% |
| Rani Therapeutics Holdings Inc (RANI) | $60.78M | N/A | 16.3x | 0.0% | N/A | 893.0% | 0.00% |
| Grace Therapeutics, Inc. (GRCE) | $38.08M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Spero Therapeutics Inc (SPRO) | $58.26M | 11.1x | 1.3x | 15.7% | N/A | -95.6% | 0.00% |
| Lite Strategy, Inc. (LITS) | $25.30M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| RenovoRx Inc (RNXT) | $50.18M | N/A | 16.6x | 0.0% | N/A | 300.8% | 0.00% |
| Instil Bio Inc. (TIL) | $41.23M | N/A | N/A | 0.0% | -11.9% | 0.0% | 0.00% |
| Peer median | $39.65M | 11.1x | 6.6x | 0.0% | -91.2% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Serina Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| OS Therapies Incorporated (OSTX) | OS Therapies Incorporated is a pioneering biopharmaceutical company committed to developing innovative treatments for unmet medical needs... | OSTX competitors |
| ProMIS Neurosciences Inc. (PMN) | ProMIS Neurosciences Inc. is a pioneering biotechnology company focused on the development of innovative therapeutic solutions for neurodegenerative diseases... | PMN competitors |
| Rein Therapeutics Inc (RNTX) | Rein Therapeutics Inc (RNTX) is a forward-thinking biopharmaceutical company dedicated to developing innovative therapies for neurodegenerative disorders... | RNTX competitors |
| Plus Therapeutics Inc (PSTV) | Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing... | PSTV competitors |
| Gain Therapeutics Inc (GANX) | Gain Therapeutics, Inc., a developing biotechnology company, is dedicated to developing a variety of therapies to treat diseases caused by protein misfolding. | GANX competitors |
| Seres Therapeutics Inc (MCRB) | Seres Therapeutics, Inc., a microbiome therapeutic platform company, is involved in the development of bacterial consortia that are designed to functionally... | MCRB competitors |
| Rani Therapeutics Holdings Inc (RANI) | Rani Therapeutics Holdings Inc. is an innovative biotechnology company transforming the landscape of drug delivery with its proprietary RaniPill™ technology... | RANI competitors |
| Grace Therapeutics, Inc. (GRCE) | Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. | GRCE competitors |
| Spero Therapeutics Inc (SPRO) | Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing... | SPRO competitors |
| Lite Strategy, Inc. (LITS) | Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer. | LITS competitors |
| RenovoRx Inc (RNXT) | RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. | RNXT competitors |
| Instil Bio Inc. (TIL) | Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer patients. | TIL competitors |
Frequently Asked Questions About SER
Who are Serina Therapeutics' main competitors?
The companies most similar to Serina Therapeutics include OS Therapies (OSTX), ProMIS Neurosciences (PMN), Rein Therapeutics (RNTX), Plus Therapeutics (PSTV) and Gain Therapeutics (GANX), listed from the closest match.
Who is Serina Therapeutics' biggest competitor?
Rani Therapeutics Holdings (RANI) is the largest of the similar companies at $60.78M; OS Therapies (OSTX) is the closest match by business profile, size, sector and industry.
How does SER stock compare with its competitors?
SER's P/S is 288.7x against a peer median of 6.6x; its net margin is 0.0% against a peer median of 0.0%.
Which of Serina Therapeutics' competitors pays a higher dividend?
Serina Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Serina Therapeutics bigger than its competitors?
No. Serina Therapeutics is 8th by market cap among the 13 companies on this page; the largest is Rani Therapeutics Holdings (RANI) at $60.78M.
SER pages: Overview, Earnings, Forecast, Financials, Competitors